Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study

11 citations , March 2021 in “Dermatology and therapy”

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

research The relationship between stress resistance and psychological well-being of counseling psychologists

May 2024 in “International journal of medicine and psychology.”

Improving stress resistance can boost the well-being of counseling psychologists.

research The development and validation of the hair shedding visual scale for Asian women (HSVS‐A)

October 2023 in “The Journal of Dermatology”

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.

Chronic Exposure of 5-Alpha Reductase Inhibitor in Young Male Rats Induces Metabolic Disturbance and Depressive-Like Behaviors

research Chronic Exposure of 5‐Alpha Reductase Inhibitor in Young Male Rats Induces Not Only Metabolic Disturbance, But Also Depressive‐Like Behaviors as Similar with Obese Condition

December 2023 in “Alzheimer's & Dementia”

Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.

research Finasteride withdrawal induces anxiety-like behavior and novelty avoidance in adult male rats.

February 2026 in “PubMed”

Finasteride withdrawal causes anxiety-like behavior in male rats.

research Administration of finasteride modulates depressive-like behavior in the forced swim task of male rats

January 2012

Physician and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries

research Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries

2 citations , October 2023 in “Dermatology and therapy”

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

research Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata

October 2025 in “Dermatology and Therapy”

research Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata

March 2026 in “SKIN The Journal of Cutaneous Medicine”

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

research Association of prior 5-α-reductase inhibitor exposure with ICI benefit in metastatic RCC: Multicentre cohort with single-cell immune profiling.

March 2026 in “Journal of Clinical Oncology”

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

← Previous page